产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS11354 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-alpha + beta Synuclein |
克隆性 | |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human alpha + beta Synuclein |
技术外包服务:
★核突触蛋白α+β抗体规格 分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
★蛋白工程:原核、哺乳动物蛋白表达系统等
★病毒包装:腺病毒、慢病毒等
★抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
实验流程:
核突触蛋白α+β抗体规格 英文名称 Anti-alpha + beta Synuclein
中文名称 核突触蛋白α+β抗体规格
别 名 Alpha synuclein; Beta synuclein; NACP; Non A beta component of AD amyloid; Non A4 component of amyloid precursor; PARK1; PARK4; Parkinson disease familial 1; PD1; SNCA; SYUA_HUMAN; SNCB; SNCB protein; Synuclein alpha; Synuclein beta; SYUB_HUMAN.
产品属性:
浓 度 1mg/1ml
规 格 0.1ml/100μg 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, zebrafinch
产品类型 一抗
研究领域 细胞生物 神经生物学 Alzheimer's
蛋白分子量 predicted molecular weight: 14kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human alpha + beta Synuclein
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
核突触蛋白α+β抗体规格 产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Synucleins are small soluble proteins expressed primarily in neural tissues and in certain tumors. The family includes 3 known proteins, alpha synuclein, beta synuclein and gamma synuclein. All synucleins have in common a highly conserved alpha helical lipid binding motif with similarity to the class A2 lipid binding domains of the exchangeable apolipoproteins. The alpha and beta synuclein proteins are found primarily in brain tissue, where they are seen mainly in pre synaptic terminals. Alpha synuclein is believed to be a major component of Lewy bodies in Parkinson’s disease. Mutations in alpha synuclein are associated with rare familial cases of early onset Parkinson’s disease, Alzheimer’s disease and several other neurodegenerative illnesses.
Function : May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.
Subunit : Soluble monomer which can form filamentous aggregates. Interacts with UCHL1 (By similarity). Interacts with phospholipase D and histones.
Subcellular Location : Cytoplasmic. Membrane bound in dopaminergic neurons. Also found in the nucleus.
Tissue Specificity : Expressed principally in brain but is also expressed in low concentrations in all tissues examined except in liver. Concentrated in presynaptic nerve terminals.
Post-translational modifications : Phosphorylated, predominantly on serine residues. Phosphorylation by CK1 appears to occur on residues distinct from the residue phosphorylated by other kinases. Phosphorylation of Ser-129 is selective and extensive in synucleinopathy lesions. In vitro, phosphorylation at Ser-129 promoted insoluble fibril formation. Phosphorylated on Tyr-125 by a PTK2B-dependent pathway upon osmotic stress.
Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers.
Ubiquitinated. The predominant conjugate is the diubiquitinated form (By similarity).
DISEASE : Note=Genetic alterations of SNCA resulting in aberrant polymerization into fibrils, are associated with several neurodegenerative diseases (synucleinopathies). SNCA fibrillar aggregates represent the major non A-beta component of Alzheimer disease amyloid plaque, and a major component of Lewy body inclusions. They are also found within Lewy body (LB)-like intraneuronal inclusions, glial inclusions and axonal spheroids in neurodegeneration with brain iron accumulation type 1.
Defects in SNCA are the cause of Parkinson disease type 1 (PARK1) [MIM:168601]. A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features.
Defects in SNCA are the cause of Parkinson disease type 4 (PARK4) [MIM:605543]. A complex neurodegenerative disorder with manifestations ranging from typical Parkinson disease to dementia with Lewy bodies. Clinical features include parkinsonian symptoms (tremor, rigidity, postural instability and bradykinesia), dementia, diffuse Lewy body pathology, autonomic dysfunction, hallucinations and paranoia.
Defects in SNCA are the cause of dementia Lewy body (DLB) [MIM:127750]. A neurodegenerative disorder clinically characterized by mental impairment leading to dementia, parkinsonism, often with fluctuating cognitive function, visual hallucinations, falls, syncopal episodes, and sensitivity to neuroleptic medication. Brainstem or cortical intraneuronal accumulations of aggregated proteins (Lewy bodies) are the only essential pathologic features. Patients may also have hippocampal and neocortical senile plaques, sometimes in sufficient number to fulfill the diagnostic criteria for Alzheimer disease.
Similarity : Belongs to the synuclein family.
Database links : UniProtKB/Swiss-Prot: P37840.1 UniProtKB/Swiss-Prot: Q16143.1
全、新、优、品、好四大特点:
核突触蛋白α+β抗体规格 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。
新:产品更新速度较快,基本上每周都有新产品出现。
优:产品质量好,投诉比较少。
好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
正在热销的相关产品:
phosphor-SMAD(p-Ser425)、phosphor-Mothers against decapentaplegic 磷酸化SMAD(p-Ser425)抗原Multi-class antibodies规格: 0.5mg
Anti-BMP4 骨形态发生蛋白4抗体Multi-class antibodies规格: 0.2ml
Rhesus antibody Rh PFKFB1 果糖-2,6-二磷酸酶1抗体 规格 0.2ml
Cyclin G1 浓缩液 0.1ml 进口分装
EDA2R 英文名称: 坏死因子受体超家族成员27抗体 0.2ml
CD57 英文名称: 髓鞘相关糖蛋白CD57抗体 0.1ml
Anti-BMP4 骨形态发生蛋白4抗体Multi-class antibodies规格: 0.2ml
Anti-PDE4D/FITC 荧光素标记磷酸二酯酶4D抗体IgGMulti-class antibodies规格: 0.2ml
Rabbit Anti-Dog IgG/FITC 荧光素标记兔抗狗IgGMulti-class antibodies规格: 0.3ml
DNA甲基转移酶-3α抗体 Anti-Dnmt3a 0.1ml
Goat Anti-human IgG/FITC FITC标记的羊抗人IgG 0.3ml
FRG2B 英文名称: FRG2B蛋白抗体 0.2ml
Rhesus antibody Rh phospho-TRADD(Ser269) 磷酸化坏死因子受体1相关死亡域蛋白抗体 规格 0.1ml
Rabbit Anti-Dog IgG/FITC 荧光素标记兔抗狗IgGMulti-class antibodies规格: 0.3ml
Lgr5/GPR49 肠上皮干细胞蛋白(多肽)Multi-class antibodies规格: 0.5mg
Anti-AGEs 晚期糖基化终末产物抗体Multi-class antibodies规格: 0.1ml
Rhesus antibody Rh Phospho-CaMKII (Thr286) 磷酸化钙/钙调素依赖蛋白激酶2α抗体 规格 0.1ml
Avidin阻挡剂 10ml Sigma原料
VANGL2 英文名称: 神经管畸形相关蛋白VANGL2抗体 0.2ml
DMAP1 英文名称: DNA甲基转移酶相关蛋白1抗体 0.2ml
Anti-AGEs 晚期糖基化终末产物抗体Multi-class antibodies规格: 0.1ml
IL36G Protein Human 重组人 IL36G / IL1F9 蛋白 (aa 18-169, His 标签)
大鼠牙细胞完全培养基 100mL
EFNA5 Others Cynomolgus 食蟹猴 Ephrin-A5 / EFNA5 人细胞裂解液 (阳性对照)
PIEC猪髋动脉内皮细胞 PIEC pig iliac artery endothelial cells RPMI-1640(GIBCO)+10%FBS
CL-0411PA-1(人卵巢腺癌细胞)5×106cells/瓶×2
NCTC 1469(小鼠正常肝细胞) 5×106cells/瓶×2 HCT 116(细胞)
CM-R057大鼠肾系膜细胞完全培养基100mL
CD226 Others Rat 大鼠 CD226 / DNAM-1 人细胞裂解液 (阳性对照)
大鼠腹脊髓神经元RN-vsc
JEG细胞,人 大鼠肝细胞,IAR20细胞 人成纤维细胞-心房HCF-aa
HuTu-80(人十二脂肠腺癌) 5×106cells/瓶×2
769-P(人肾细胞腺癌细胞) 5×106cells/瓶×2 CM-H083人脐动脉内皮细胞完全培养基100mL 人间充质干细胞-骨髓RNAHMSC-bm miRNA5 μg
核突触蛋白α+β抗体规格 IL36G Protein Human 重组人 IL36G / IL1F9 蛋白 (aa 18-169, His 标签)
大鼠牙细胞完全培养基 100mL
EFNA5 Others Cynomolgus 食蟹猴 Ephrin-A5 / EFNA5 人细胞裂解液 (阳性对照)
PIEC猪髋动脉内皮细胞 PIEC pig iliac artery endothelial cells RPMI-1640(GIBCO)+10%FBS
CL-0411PA-1(人卵巢腺癌细胞)5×106cells/瓶×2
NCTC 1469(小鼠正常肝细胞) 5×106cells/瓶×2 HCT 116(细胞)